Systemic Chemotherapy Combined With Recombinant Human Adenovirus Type 5 and Endostatin Injections for Treatment Malignant Hydrothorax in NSCLC Patients
Clinical trial NCT02579564 · UNKNOWN
Trial details
- NCT number
- NCT02579564
- Sponsor
- Xinqiao Hospital of Chongqing
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-01
- Primary completion
- 2018-06-01
- Enrollment
- 134
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.